Strumento inattivo

Altre lingue Coronado Biosciences Inc Nasdaq

Azioni

US21976U1097

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Fortress Biotech, Inc.(NasdaqCM:FBIO) added to Russell 3000E Index	01/07
Fortress Biotech, Inc.(NasdaqCM:FBIO) added to Russell Microcap Index	01/07
Fortress Biotech, Inc.(NasdaqCM:FBIO) added to Russell Microcap Growth Index	01/07
Fortress Biotech, Inc.(NasdaqCM:FBIO) added to Russell 3000E Growth Index	01/07
Fortress Biotech, Inc.(NasdaqCM:FBIO) added to Russell Microcap Value Index	01/07
Fortress Biotech, Inc.(NasdaqCM:FBIO) added to Russell 3000E Value Index	01/07
Fortress Biotech : Private Placement Form 8 K	28/06
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase	16/05
Fortress Biotech: Q1 Earnings Snapshot	15/05
Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M	15/05
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	15/05
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase	15/05
Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex	14/05
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation	14/05
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation	14/05
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	13/05
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024	07/05
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer	01/05
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds	29/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Coronado Biosciences Inc Nasdaq

Azioni

US21976U1097

Altre lingue

Filtri